Studies have shown immediate-release opioids can be used supplementally when transdermal buprenorphine is being used to manage moderate-to-severe chronic pain.
The study cleared up confusion as whether or not immediate-release opioids would properly function with buprenorphine, which may displace or prevent competing mu-opioid agonists from binding.
More Articles on Anesthesia:
Drug EXPAREL Reduces Pain, Adverse Opioid Side Effects
Donald Bell Elected to Chair Tennessee Board of Nursing
Dr. Andrew Greenfield Named Senior VP of Anesthesiology at Sheridan Healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
